SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-030542
Filing Date
2009-05-07
Accepted
2009-05-07 16:54:19
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a09-11020_110q.htm 10-Q 807568
2 EX-10.4 a09-11020_1ex10d4.htm EX-10.4 157434
3 EX-10.52 a09-11020_1ex10d52.htm EX-10.52 41456
4 EX-31.1 a09-11020_1ex31d1.htm EX-31.1 12460
5 EX-31.2 a09-11020_1ex31d2.htm EX-31.2 13210
6 EX-32 a09-11020_1ex32.htm EX-32 11641
  Complete submission text file 0001104659-09-030542.txt   1045253
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 09806251
SIC: 2834 Pharmaceutical Preparations